Occudo Quantitative Strategies LP Intercept Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $172,527 - $323,121	17,270 New	17,270 $320,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $570,451 - $920,384	46,720 Added 275.15%	63,700 $889,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $202,263 - $352,835	-18,011 Reduced 51.47%	16,980 $234,000
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $467,829 - $622,489	34,991 New	34,991 $569,000
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $629,616 - $1.23 Million	-32,572 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $797,362 - $1.38 Million	32,572 New	32,572 $805,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.